Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Grant revenue $ 13,163 $ 30,187
Operating expenses:        
Research and development 906,779 2,006,696 1,570,193 3,679,272
General and administrative 1,399,221 1,115,785 3,195,910 2,365,048
Total operating expenses 2,306,000 3,122,481 4,766,103 6,044,320
Loss from operations (2,306,000) (3,109,318) (4,766,103) (6,014,133)
Other income (expense):        
Interest income 6,405 58,954 25,640 121,155
Interest expense (1,803) (843) (8,888) (4,190)
Other income 621 1,745
Foreign currency exchange net (3,692) (6,572)
Total other income, net 910 58,732 10,180 118,710
Loss before income taxes (2,305,090) (3,050,586) (4,755,923) (5,895,423)
Income tax benefit
Net loss $ (2,305,090) $ (3,050,586) $ (4,755,923) $ (5,895,423)
Basic net loss per share $ (0.51) $ (1.51) $ (1.19) $ (3.04)
Diluted net loss per share $ (0.51) $ (1.51) $ (1.19) $ (3.04)
Shares used to compute basic net loss per share 4,529,045 2,024,766 4,012,561 1,941,858
Shares used to compute diluted net loss per share 4,529,045 2,024,766 4,012,561 1,941,858